Chelsea Therapeutics to Present at the 2013 Wedbush Life Sciences Management Access Conference
August 07, 2013 07:00 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., Aug. 7, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 2013 Wedbush Life Sciences Management Access Conference at 10:20...
Chelsea Therapeutics Reports Second Quarter 2013 Financial Results
August 06, 2013 16:11 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the second quarter ended June 30, 2013.
"Chelsea...
Chelsea Therapeutics Announces Update to NORTHERA(TM) (Droxidopa) NDA Filing
July 29, 2013 07:30 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., July 29, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that the U.S. Food and Drug Administration (FDA), upon further review of the...
Chelsea Therapeutics Announces FDA Acceptance of NORTHERA(TM) (droxidopa) NDA Resubmission
July 17, 2013 09:30 ET
|
Chelsea Therapeutics
PDUFA Date Set as January 3, 2014
CHARLOTTE, N.C., July 17, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that the U.S. Food and Drug...
Chelsea Therapeutics Resubmits New Drug Application for NORTHERA(TM) (droxidopa) for the Treatment of Symptomatic NOH
July 09, 2013 07:30 ET
|
Chelsea Therapeutics
• Submission Includes Successful 300 mg Bioequivalence Study
• Six Month Review Decision Expected Under PDUFA
CHARLOTTE, N.C., July 9, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics...
Chelsea Therapeutics Added to Russell 3000(R) and Russell 2000(R) Indexes
July 01, 2013 07:00 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., July 1, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that it was added to the Russell 3000® and Russell 2000® Indexes when...
Chelsea Therapeutics to Present at the 38th Annual Deutsche Bank Health Care Conference
May 22, 2013 08:00 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., May 22, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 38th Annual Deutsche Bank Health Care Conference at 4:50 PM on...
Chelsea Therapeutics Reports First Quarter 2013 Financial Results
May 01, 2013 16:16 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., May 1, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today reported financial results for the first quarter ended March 31, 2013.
"In the first...
Chelsea Therapeutics to Present at the 12th Annual Needham Healthcare Conference
April 24, 2013 09:25 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., April 24, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present the 12th Annual Needham Healthcare Conference at 10:40 AM on...
Chelsea Therapeutics Announces Presentation of Northera(TM) (droxidopa) Study 306 Data at the American Academy of Neurology Annual Meeting
March 19, 2013 08:00 ET
|
Chelsea Therapeutics
CHARLOTTE, N.C., March 19, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that Dr. Stuart Isaacson, Clinical Associate Professor, Department of...